Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276).
Fei ZhouTingting PanXiaoli LiFeng DuXiao MaYanming ZhangDepei WuYue HanSheng-Li XueMiao MiaoTao TaoXuefeng HeSuning ChenPublished in: Bone marrow transplantation (2023)